Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women

Osteoporosis International

Volumn 23, Issue 2, 2012, Pages 445-455

  Breuil, V ^a   Cortet, B ^b   Cotte F E ^c   Arnould, B ^d   Dias Barbosa, C ^d   Gaudin, A F ^c   Regnault, A ^d   Roborel De Climens, A ^d   Legrand, E ^e  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c GLAXOSMITHKLINE   (France)

^d MAPI VALUES   (United States)

^e ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Adherence; Compliance; Patient related outcomes; Persistence; Post menopausal osteoporosis; Questionnaire

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STRONTIUM RANELATE;

ADHERENCE EVALUATION OF OSTEOPOROSIS TREATMENT; ADULT; AGED; ARTICLE; CONCURRENT VALIDITY; DISCRIMINANT VALIDITY; DRUG DOSE REGIMEN; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORISKY MEDICATION ADHERENCE SCALE; PATIENT COMPLIANCE; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROBABILITY; QUESTIONNAIRE; RATING SCALE; RISK ASSESSMENT; SCORING SYSTEM; SELF REPORT; TREATMENT WITHDRAWAL;

AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; BONE DENSITY CONSERVATION AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PSYCHOMETRICS; QUESTIONNAIRES;

EID: 84857370764     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-011-1555-8     Document Type: Article

References (46)

1. National Institute of Health 2001 Osteoporosis prevention, diagnosis, and therapy JAMA 285 785 795 10.1001/jama.285.6.785
2. JA Kanis A Oden O Johnell C De Laet B Jonsson 2004 Excess mortality after hospitalisation for vertebral fracture Osteoporos Int 15 108 112 14598026 10.1007/s00198-003-1516-y
3. LJ Melton 3rd 2000 Excess mortality following vertebral fracture J Am Geriatr Soc 48 338 339 10733065
4. LJ Melton 3rd M Thamer NF Ray JK Chan CH Chesnut 3rd TA Einhorn CC Johnston LG Raisz SL Silverman ES Siris 1997 Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation J Bone Miner Res 12 16 23 9240721 10.1359/jbmr.1997.12.1.16
5. JA Kanis CC Gluer 2000 An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation Osteoporos Int 11 192 202 10824234 10.1007/s001980050281 1:STN:280:DC%2BD3c3osVanug%3D%3D
6. PD Delmas 2005 The use of bisphosphonates in the treatment of osteoporosis Curr Opin Rheumatol 17 462 466 15956844 1:CAS:528: DC%2BD2MXlt1Sms70%3D
7. L Gennari D Merlotti F Valleggi G Martini R Nuti 2007 Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development Drugs Aging 24 361 379 17503894 10.2165/00002512-200724050-00002 1:CAS:528:DC%2BD2sXot1GjsbY%3D
8. C Roux J Fechtenbaum S Kolta G Isaia JB Andia JP Devogelaer 2008 Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis Ann Rheum Dis 67 1736 1738 18713788 10.1136/ard.2008.094516 1:STN:280:DC%2BD1cjjsVersw%3D%3D
9. SK Blick S Dhillon SJ Keam 2008 Teriparatide: a review of its use in osteoporosis Drugs 68 2709 2737 19093708 10.2165/0003495-200868180-00012 1:CAS:528:DC%2BD1MXislKhtrs%3D
10. JA Cramer DT Gold SL Silverman EM Lewiecki 2007 A systematic review of persistence and compliance with bisphosphonates for osteoporosis Osteoporos Int 18 1023 1031 17308956 10.1007/s00198-006-0322-8 1:CAS:528:DC%2BD2sXntVOlsrY%3D
11. P Kothawala E Badamgarav S Ryu RM Miller RJ Halbert 2007 Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis Mayo Clin Proc 82 1493 1501 18053457 10.4065/82.12.1493
12. DT Gold S Silverman 2006 Review of adherence to medications for the treatment of osteoporosis Curr Osteoporos Rep 4 21 27 16527004 10.1007/s11914-006-0011-8
13. J Adachi N Lynch H Middelhoven M Hunjan W Cowell 2007 The association between compliance and persistence with bisphosphonate therapy and fracture risk: a review BMC Musculoskelet Disord 8 97 17897451 10.1186/1471-2474-8-97
14. Imaz I, Zegarra P, González-Enríquez J, Rubio B, Alcazar R, Amate JM (2009) Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int. E-pub 9th December 2009
15. FJ Penning-van Beest JA Erkens M Olson RM Herings 2008 Loss of treatment benefit due to low compliance with bisphosphonate therapy Osteoporos Int 19 511 517 17874028 10.1007/s00198-007-0466-1 1:STN:280:DC%2BD1c7nvFWqtw%3D%3D
16. FJ Penning-van Beest WG Goettsch JA Erkens RM Herings 2006 Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis Clin Ther 28 236 242 16678644 10.1016/j.clinthera.2006.01.002 1:CAS:528:DC%2BD28Xmtl2ltrg%3D
17. J Kertes M Dushenat JL Vesterman J Lemberger J Bregman N Friedman 2008 Factors contributing to compliance with osteoporosis medication Isr Med Assoc J 10 207 213 18494234
18. F Lekkerkerker JA Kanis N Alsayed G Bouvenot N Burlet D Cahall A Chines P Delmas RL Dreiser D Ethgen N Hughes JM Kaufman S Korte G Kreutz A Laslop B Mitlak V Rabenda R Rizzoli A Santora R Schimmer Y Tsouderos P Viethel JY Reginster 2007 Adherence to treatment of osteoporosis: a need for study Osteoporos Int 18 1311 1317 17585359 10.1007/s00198-007-0410-4 1:STN:280:DC%2BD2srjtVensw%3D%3D
19. JA Cramer A Roy A Burrell CJ Fairchild MJ Fuldeore DA Ollendorf PK Wong 2008 Medication compliance and persistence: terminology and definitions Value Health 11 44 47 18237359 10.1111/j.1524-4733.2007.00213.x
20. JF Steiner AV Prochazka 1997 The assessment of refill compliance using pharmacy records: methods, validity, and applications J Clin Epidemiol 50 105 116 9048695 10.1016/S0895-4356(96)00268-5 1:STN:280:DyaK2s3gtVyltA%3D%3D
21. DE Morisky LW Green DM Levine 1986 Concurrent and predictive validity of a self-reported measure of medication adherence Med Care 24 67 74 3945130 10.1097/00005650-198601000-00007 1:STN:280:DyaL287hslWjsg%3D%3D
22. K Thompson J Kulkarni AA Sergejew 2000 Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses Schizophr Res 42 241 247 10785582 10.1016/S0920-9964(99)00130-9 1:STN:280:DC%2BD3c3kvFShtQ%3D%3D
23. S Kripalani J Risser ME Gatti TA Jacobson 2009 Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease Value Health 12 118 123 19911444 10.1111/j.1524-4733.2008.00400.x
24. SR Hahn J Park EP Skinner KS Yu-Isenberg MB Weaver B Crawford PW Flowers 2008 Development of the ASK-20 adherence barrier survey Curr Med Res Opin 24 2127 2138 18554431 10.1185/03007990802174769
25. X Girerd O Hanon K Anagnostopoulos C Ciupek JJ Mourad S Consoli 2001 Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic Presse Méd 30 1044 1048 11471275 1:STN:280:DC%2BD3MvisVKlsA%3D%3D
26. S Bouée A Charlemagne F Fagnani P Le Jeunne C Sermet F Naudin PJ Lancry 2004 Changes in osteoarthritis management by general practitioners in the COX2-inhibitor era-concomitant gastroprotective therapy Joint Bone Spine 71 214 220 15182793 10.1016/S1297-319X(03)00158-1
27. JA Cramer NO Lynch AF Gaudin M Walker W Cowell 2006 The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: a comparison of studies in the United States, the United Kingdom, and France Clin Ther 28 1686 1694 17157124 10.1016/j.clinthera.2006.10. 013 1:CAS:528:DC%2BD28XhtlartrvP
28. FE Cotté P Fardellone F Mercier AF Gaudin C Roux 2010 Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis Osteoporos Int 21 145 155 19459025 10.1007/s00198-009-0930-1
29. A Crochard A El Hasnaoui D Pouchain D Huas I Arnulf J Krieger E Lainey P Le Jeunne D Léger S Schuck N Texier F Tison J Montplaisir 2007 Diagnostic indicators of restless legs syndrome in primary care consultations: the DESYR study Mov Disord 22 791 797 17230475 10.1002/mds.21325
30. O Chassany P Le-Jeunne M Duracinsky MS Schwalm M Mathieu 2006 Discrepancies between patient-reported outcomes and clinician-reported outcomes in chronic venous disease, irritable bowel syndrome, and peripheral arterial occlusive disease Value Health 9 39 46 16441523 10.1111/j.1524-4733.2006.00079.x
31. E Van Ganse L Laforest E Alemao G Davies S Gutkin D Yin 2005 Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study Curr Med Res Opin 21 1389 1399 16197657 10.1185/030079905X59139
32. F Fagnani M German-Fattal 2003 Antibiotic prescribing patterns of French GPs for upper respiratory tract infections: impact of fusafungine on rates of prescription of systemic antibiotics Am J Respir Med 2 491 498 14719988
33. V Bagneux N Barnes B Arnould 2007 Development of a standardized face and content validity test to evaluate patient questionnaires for clinical practice PRO Newsl 38 12 14
34. JJ Caro KJ Ishak KF Huybrechts G Raggio C Naujoks 2004 The impact of compliance with osteoporosis therapy on fracture rates in actual practice Osteoporos Int 15 1003 1008 15167989 10.1007/s00198-004-1652-z
35. FE Cotté F Mercier G De Pouvourville 2008 Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: a retrospective case-control analysis Clin Ther 30 2410 2422 19167600 10.1016/j.clinthera.2008.12.019
36. D Huas F Debiais F Blotman B Cortet F Mercier C Rousseaux V Berger AF Gaudin FE Cotté 2010 Compliance and treatment satisfaction of post menopausal women treated for osteoporosis BMC Womens Health 10 26 20727140 10.1186/1472-6874-10-26
37. MC Garber DP Nau SR Erickson JE Aikens JB Lawrence 2004 The concordance of self-report with other measures of medication adherence: a summary of the literature Med Care 42 649 652 15213489 10.1097/01.mlr.0000129496.05898.02
38. DP Nau DT Steinke LK Williams R Austin JE Lafata G Divine M Pladevall 2007 Adherence analysis using visual analog scale versus claims-based estimation Ann Pharmacother 41 1792 1797 17925497 10.1345/aph.1K264
39. MJ Reinhard CH Hinkin TR Barclay AJ Levine S Marion SA Castellon D Longshore T Newton RS Durvasula MN Lam H Myers 2007 Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates Addict Behav 32 2727 2736 17499443 10.1016/j.addbeh.2007.04.006 1:STN:280:DC%2BD2srnvFCrsQ%3D%3D
40. NS Jentzsch PA Camargos EA Colosimo J Bousquet 2009 Monitoring adherence to beclomethasone in asthmatic children and adolescents through four different methods Allergy 64 1458 1462 19416142 10.1111/j.1398-9995.2009.02037.x 1:CAS:528:DC%2BD1MXhtlSktL%2FL
41. N van de Steeg M Sielk M Pentzek C Bakx A Altiner 2009 Drug-adherence questionnaires not valid for patients taking blood-pressure-lowering drugs in a primary health care setting J Eval Clin Pract 15 468 472 19366389 10.1111/j.1365-2753.2008.01038.x
42. MA Chisholm CE Lance GM Williamson LL Mulloy 2005 Development and validation of the immunosuppressant therapy adherence instrument (ITAS) Patient Educ Couns 59 13 20 16198214 10.1016/j.pec.2004.09.003
43. E de Klerk D van der Heijde H van der Tempel S van der Linden 1999 Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy J Rheumatol 26 2635 2641 10606375
44. M Vandekerckhove E Vermeire A Weeren P Van Royen 2009 Validation of the Diabetes Obstacles Questionnaire (DOQ) to assess obstacles in living with type 2 diabetes in a Belgian population Prim Care Diab 3 43 47 10.1016/j.pcd.2009.02. 003 1:STN:280:DC%2BD1M3ktlOguw%3D%3D
45. E Lau A Papaioannou L Dolovich J Adachi AM Sawka S Burns K Nair A Pathak 2008 Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women Can Fam Physician 54 394 402 18337534
46. Foddy W (1993) Constructing questions for interviews and questionnaires: theory and practice in social research. Cambridge University Press, Cambridge